FREE SHIPPING ON ORDERS OVER $150

glutathione for cancer treatments and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione-mediated nanomedicines for cancer diagnosis

$21.47

Quantity
- +
Description

10.1016/j.btre.2019.e00370 81 KurutasE

glutathione for cancer treatments and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione-mediated nanomedicines for cancer diagnosis

Acta Physiol Plant 39:19 Dong S, Gao M, Bo Z, Guan L, Hu X, Zhang H, Liu B, Li P, He K, Liu X (2020) Production and characterization of a single-chain variable fragment antibody from a site-saturation mutagenesis library derived from the anti-Cry1A monoclonal antibody

glutathione for cancer treatments and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione-mediated nanomedicines for cancer diagnosis

Gene polymorphisms in the heme degradation pathway and outcome of severe human sepsis

glutathione for cancer treatments and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione-mediated nanomedicines for cancer diagnosis

PMID 8492341

glutathione for cancer treatments and Thioredoxin Antioxidant Pathways Synergize to Drive Initiation and Progression Glutathione-mediated nanomedicines for cancer diagnosis

You may also like

recommand products